Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.32015 ↗At a glance
Journal article in Pediatric Blood & Cancer, 2025. Written by Michael D Fox and 11 co-authors. Institution: Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Proto-Oncogene Proteins B-raf, Lymphatic Abnormalities, Mutation. 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: Intramural NIH HHS, Intramural Research Program of the National Institutes of Health (NIH).
Abstract (original language)
Background
The somatic activating variant in BRAF (p.V600E) was recently described as a novel cause of macrocystic head and neck lymphatic malformations in three individuals. Other recent studies profiling the genetic causes of more complex lymphatic anomalies identified this same pathogenic BRAF variant. Our aim was to expand the phenotypic description of the somatic BRAF p.V600E variant in individuals with vascular anomalies. Procedure We searched the database of individuals with vascular anomalies at our institution for those identified as having complex lymphatic anomalies and somatic BRAF p.V600E variants. A comprehensive retrospective review of identified individuals’ electronic health records was conducted.
Results
Six individuals with complex lymphatic anomalies had the BRAF p.V600E variant. All individuals had diffuse lymphatic malformations and abnormal lymphatic conduction. The conduction abnormalities were observed only after surgical interventions in five of the patients, in some cases, manifesting years later. There was immense phenotypic heterogeneity within the cohort.
Conclusions
Complex lymphatic anomalies are an important new phenotype associated with the pathogenic BRAF p.V600E variant. Even in initially asymptomatic individuals within this patient population, longitudinal follow‐up is necessary, and surgical intervention should be pursued with caution. Further investigation is needed to better understand the etiology of the conduction problems associated with this pathogenic variant to inform the multidisciplinary approach to treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Division of Interventional Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Division of Pediatric Hematology-Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID profiles: Michael D Fox, Sumukh Kumar, Allison D Britt, Abhay S Srinivasan
Funding
- Intramural NIH HHS
- Intramural Research Program of the National Institutes of Health (NIH)
Cite
APA
Fox, M. D., Kumar, S., Britt, A. D., Srinivasan, A. S., Surrey, L. F., Vatsky, S. E., Borst, A. J., Hakonarson, H., Li, D., Sheppard, S. E., Snyder, K. M., & Adams, D. M. (2025). Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32015
Vancouver
Fox MD, Kumar S, Britt AD, Srinivasan AS, Surrey LF, Vatsky SE, et al. Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.32015
BibTeX
@article{Fox2025,
author = {Fox, Michael D and Kumar, Sumukh and Britt, Allison D and Srinivasan, Abhay S and Surrey, Lea F and Vatsky, Seth E and Borst, Alexandra J and Hakonarson, Hakon and Li, Dong and Sheppard, Sarah E and Snyder, Kristen M and Adams, Denise M},
title = {Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.32015}
}
EUVIMED